Erik Flahive

Erik Flahive's Title

Erik Flahive is currently positioned as a CMC-API Consultant for San Diego Operations. In this role, he leverages his extensive expertise in Chemistry, Manufacturing, and Controls (CMC) to provide strategic guidance for the development and manufacturing of Active Pharmaceutical Ingredients (APIs). His responsibilities include overseeing the production processes and ensuring regulatory compliance, which is critical for the success of pharmaceutical projects.

Erik Flahive's Education and Expertise

Erik Flahive holds a PhD in Organic Chemistry from Arizona State University, where he also served as a faculty research associate at the Cancer Research Institute. His academic background is further bolstered by a BS in Chemistry with a minor in Biology from Georgetown University. This strong educational foundation has equipped him with advanced knowledge in organic chemistry, drug development, and biological sciences, making him a highly proficient consultant in the pharmaceutical industry.

Erik Flahive's Professional Background

Erik Flahive has a rich professional background with experience at leading pharmaceutical companies such as Pfizer-La Jolla, Ardea Biosciences, and Trius Therapeutics. At Pfizer, he led research teams working on projects in oncology, anti-viral, and ophthalmology disease areas. His notable achievements include the successful delivery of the commercial API manufacturing routes used for FDA-approved medicines for gout (Zurampic) and MRSA skin infections (Sivextro). His work has had a significant impact on the development of critical medicines.

Erik Flahive's Achievements

One of Erik Flahive's remarkable achievements includes successfully delivering the commercial API manufacturing routes for FDA-approved medicines such as Zurampic for gout and Sivextro for MRSA skin infections. Additionally, during his tenure at Pfizer, he led research teams that contributed to significant advancements in oncology, anti-viral, and ophthalmology therapeutics. His work on the synthesis of anti-cancer marine natural products further underscores his contributions to pharmaceutical research and development.

Erik Flahive's Consultant Business

Since 2014, Erik Flahive has been operating a consultant business based in San Diego. He has collaborated with over eight clients on various projects, ranging from pre-Investigational New Drug (pre-IND) programs to New Drug Application (NDA) stage programs. His consultancy offers specialized services in CMC-API development, providing clients with the expertise needed to navigate the complex processes of drug development and regulatory compliance. This consultancy underscores his commitment to advancing pharmaceutical innovations.